Livzon Group Fuzhou Fuxing Pharmaceutical is an API manufacturer based in China. It holds 15 active US drug master files and 14 valid CEPs across a filed portfolio of 17 molecules. Its GMP standing is certified by US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 5 April 2024 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Jiangyin, China | Not on file |
| Fuzhou, China | Not on file |
| Fujian, China | Not on file |
| China, China | 3006772356 |
| Molecule | Regulators | Docs |
|---|---|---|
| Colistimethate | EDQM, SFDA (Saudi Arabia), US FDA | 4 |
| Tobramycin | EDQM, US FDA | 4 |
| Vancomycin | SFDA (Saudi Arabia), US FDA | 4 |
| Daptomycin | SFDA (Saudi Arabia), US FDA | 3 |
| Teicoplanin | EDQM, SFDA (Saudi Arabia) | 3 |
| Vancomycin Hydrochloride | EDQM | 3 |
| Acarbose | EDQM, US FDA | 2 |
| Milbemycin Oxime For Veterinary Use | EDQM | 2 |
| Polymyxin B | EDQM, US FDA | 2 |
| Colistin | EDQM | 1 |
| Dalbavancin | US FDA | 1 |
| Gentamicin | US FDA | 1 |
| Kanamycin | US FDA | 1 |
| Moxidectin | US FDA | 1 |
| Moxidectin For Veterinary Use | EDQM | 1 |
| Sirolimus | US FDA | 1 |
| Telavancin | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 1 | None |
| US FDA | None | 1 |
| EMA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Livzon Group Fuzhou Fuxing Pharmaceutical comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.